Priority Date: 14.11.05 (EP 20050110689)

USE OF PIMOBENDAN FOR THE TREATMENT OF ASYMPTOMATIC (OCCULT) HEART FAILURE

  • Application ID: EP06829958
  • Status: The patent has been granted

Applicant

Attorneys

no operation time available
2 offices
Technology Company
no operation time available
2 offices
Technology Company
Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 6 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Boehringer Ingelheim GmbH is specialized in A61. Boehringer Ingelheim GmbH, Boehringer Ingelheim GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 14.11.2005 - Priority Date (EP 20050110689)
  • 18.05.2007 - Publication A2 (WO2007054514)
  • 06.08.2008 - Publication A2 (EP1951227)
  • 12.04.2017 - Publication B1 (EP1951227)